Drospirenone (Slynd®) 4mg tablets re-classified as a special container
Following representations from Community Pharmacy England, the Department of Health of Social Care (DHSC) has re-determined the special container status of Drospirenone (Slynd®) 4mg tablets. From 1 June 2024, Drospirenone (Slynd®) 4mg tablets were re-classified as a special container at sub-pack level (sub-pack of 28) as they meet the relevant criteria as set out in Part II [...]
The post Drospirenone (Slynd®) 4mg tablets re-classified as a special container appeared first on Community Pharmacy England.
Recent Comments